• 1. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 2. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 3. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives Chlorinated biphenyls

Chemical Profile of Benzene,1,2-dichloro-4-(4-nitrophenoxy)- (CAS No: 22532-80-5)

Benzene,1,2-dichloro-4-(4-nitrophenoxy)-, identified by its Chemical Abstracts Service (CAS) number 22532-80-5, is a significant compound in the realm of organic chemistry and pharmaceutical research. This molecule, featuring a dichlorobenzene core substituted with a nitrophenoxyl group, exhibits unique structural and functional properties that make it a subject of considerable interest in synthetic chemistry and drug development.

The structural framework of Benzene,1,2-dichloro-4-(4-nitrophenoxy)- consists of a benzene ring substituted at the 1 and 2 positions with chlorine atoms, and at the 4 position with a phenoxy group that is further functionalized with a nitro group. This arrangement imparts distinct electronic and steric properties to the molecule, influencing its reactivity and potential applications. The presence of both electron-withdrawing (nitro) and electron-donating (chlorine) groups creates a complex interplay of effects that can be exploited in various chemical transformations.

In recent years, researchers have been exploring the synthetic utility of Benzene,1,2-dichloro-4-(4-nitrophenoxy)- as a precursor in the development of novel pharmaceutical agents. The nitrophenoxyl moiety, in particular, has been investigated for its potential role in modulating biological pathways. For instance, derivatives of this compound have shown promise in preclinical studies as intermediates for drugs targeting neurological disorders. The dichlorobenzene moiety enhances the molecule's lipophilicity, facilitating its absorption and distribution within biological systems.

The compound's reactivity also makes it a valuable tool in medicinal chemistry. The nitro group can be reduced to an amine under specific conditions, allowing for further functionalization. This transformation opens up avenues for creating more complex molecules with tailored biological activities. Additionally, the chlorine atoms can participate in nucleophilic aromatic substitution reactions, enabling the introduction of diverse substituents at strategic positions on the benzene ring.

Recent advancements in computational chemistry have further illuminated the potential of Benzene,1,2-dichloro-4-(4-nitrophenoxy)-. Molecular modeling studies suggest that this compound can interact with specific biological targets through both hydrophobic and hydrogen bonding interactions. These insights have guided the design of more potent and selective derivatives for therapeutic applications. For example, modifications to the nitrophenoxyl group have been shown to enhance binding affinity to certain enzymes involved in inflammatory responses.

The pharmaceutical industry has taken note of these findings, leading to increased interest in licensing or developing drugs based on analogs of Benzene,1,2-dichloro-4-(4-nitrophenoxy)-. Several companies are currently engaged in clinical trials evaluating the efficacy and safety of compounds derived from this scaffold. Early results are promising, indicating that these molecules may offer novel therapeutic strategies for conditions such as pain management and neurodegenerative diseases.

Beyond pharmaceutical applications, Benzene,1,2-dichloro-4-(4-nitrophenoxy)- has found utility in materials science. Its unique electronic properties make it suitable for use as an intermediate in the synthesis of organic semiconductors and conductive polymers. These materials are being explored for applications in flexible electronics and energy storage devices due to their ability to transport charge efficiently.

The synthesis of Benzene,1,2-dichloro-4-(4-nitrophenoxy)- itself is an intriguing challenge that has driven innovation in synthetic methodologies. Researchers have developed efficient multi-step routes to this compound using palladium-catalyzed cross-coupling reactions and other advanced techniques. These methods not only improve yield but also minimize waste generation, aligning with growing environmental concerns in chemical manufacturing.

In conclusion,Benzene, 1, 2-dichloro-4-(4-nitrophenoxy) (CAS No: 22532/80/5) represents a versatile compound with broad applications across multiple scientific disciplines. Its unique structure and reactivity continue to inspire new research directions in pharmaceuticals and materials science. As our understanding of its properties deepens,Benzene, 1, 2-dichloro-4-(4-nitrophenoxy) is poised to play an increasingly important role in addressing some of today's most pressing scientific challenges.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)